Toca 511, is a replication competent RV encoding CD that has demonstrated to promote tumor eradication in mouse glioma models (Ostertag et al., 2012), together with durable antitumor immune responses (Mitchell et al., 2017). Here, CTLA4 is linked to neoplasm.